CRISPR/Cas9-Mediated SHP-1-Knockout T Cells Combined with Simvastatin Exhibit Enhanced Anti-Tumor Activity in Hepatocellular Carcinoma
收藏Mendeley Data2026-04-09 收录
官方服务：
资源简介：
Sample at figure 6 and supplementary figure 10
社区交流群
科研交流群
商业服务
Sample at figure 6 and supplementary figure 10